Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes

被引:5
|
作者
Cho, Yoosun [1 ]
Chang, Yoosoo [2 ,3 ,4 ,8 ]
Ryu, Seungho [2 ,3 ,4 ,8 ]
Wild, Sarah H. [5 ]
Byrne, Christopher D. [6 ,7 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Ctr Cohort Studies, Sch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Sch Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea
[5] Univ Edinburgh, Usher Inst, Edinburgh, Scotland
[6] Univ Southampton, Fac Med, Nutr & Metab, Southampton, England
[7] Univ Hosp Southampton, Natl Inst Hlth & Care Res, Southampton Biomed Res Ctr, Southampton, England
[8] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Sch Med, Samsung Main Bldg B2,250,Taepyung Ro 2ga, Seoul 04514, South Korea
关键词
cohort study; metabolic dysfunction-associated fatty liver disease; nonalcoholic fatty liver disease; type; 2; diabetes; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; GLUCOSE; NAFLD; PREVALENCE; FIBROSIS; OBESITY;
D O I
10.1111/liv.15661
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and AimsRe-classifying NAFLD as metabolic-associated fatty liver (MAFLD) has been proposed. While some people fulfil criteria for NAFLD, they do not have MAFLD; and whether NAFLD-only subjects have increased the risk of type 2 diabetes remains unknown. We compared risk of incident T2D in individuals with: (a) NAFLD-only; and (b) MAFLD, to individuals without fatty liver, considering effect modification by sex. Methods246 424 Koreans without diabetes or a secondary cause of ultrasound-diagnosed hepatic steatosis were studied. Subjects were stratified into: (a) NAFLD-only status and (b) NAFLD that overlapped with MAFLD (MAFLD). Cox proportional hazards models with incident T2D as the outcome were used to estimate hazard ratios (HRs) for: (a) and (b). Models were adjusted for time-dependent covariates, and effect modification by sex was analysed in subgroups. ResultsA total of 5439 participants had NAFLD-only status and 56 839 met MAFLD criteria. During a median follow-up of 5.5 years, 8402 incident cases of T2D occurred. Multivariable-adjusted HRs (95% CI) for incident T2D comparing NAFLD-only and MAFLD to the reference (neither condition) were 2.39 (1.63-3.51) and 5.75 (5.17-6.36) (women), and 1.53 (1.25-1.88) and 2.60 (2.44-2.76) (men), respectively. The increased risk of T2D in the NAFLD-only group was higher in women than in men (p for interaction by sex <0.001) and consistently observed across all subgroups. Risk of T2D was increased in lean participants regardless of metabolic dysregulation (including prediabetes). ConclusionsNAFLD-only participants without metabolic dysregulation and the criteria for MAFLD are at increased risk of developing T2D. This association was consistently stronger in women than in men.
引用
收藏
页码:2445 / 2454
页数:10
相关论文
共 50 条
  • [1] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [2] The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
    Seo, Ji-Yeon
    Bae, Jung-Ho
    Kwak, Min-Sun
    Yang, Jong-In
    Chung, Su-Jin
    Yim, Jeong-Yoon
    Lim, Seon-Hee
    Chung, Goh-Eun
    BIOMEDICINES, 2021, 9 (10)
  • [3] From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
    Kang, Seong Hee
    Cho, Yuri
    Jeong, Soung Won
    Kim, Seung Up
    Lee, Jin-Woo
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 257 - 269
  • [4] Prevalence and Impact of Fatty Liver Disease in Adult Deceased Liver Transplant Donors: Metabolic-Associated Fatty Liver Disease or Nonalcoholic Fatty Liver Disease?
    Liu, Ken
    Pandya, Keval
    West, Claire
    Virtue, Susan
    McCaughan, Geoffrey W.
    LIVER TRANSPLANTATION, 2021, 27 (10) : 1498 - 1501
  • [5] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [6] Metabolic-associated Fatty Liver Disease
    Zheng, Ming-Hua
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 793 - 794
  • [7] Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
    Ng, Cheng Han
    Huang, Daniel Q.
    Nguyen, Mindie H.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (04) : 790 - 801
  • [8] Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
    Mohammad Alomari
    Mamoon Ur Rashid
    Pravallika Chadalavada
    Jonathan Ragheb
    Hammad Zafar
    Zoilo Karim Suarez
    Shrouq Khazaaleh
    Adalberto Jose Gonzalez
    Fernando J Castro
    World Journal of Hepatology, 2023, (04) : 477 - 496
  • [9] Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
    Alomari, Mohammad
    Rashid, Mamoon Ur
    Chadalavada, Pravallika
    Ragheb, Jonathan
    Zafar, Hammad
    Suarez, Zoilo Karim
    Khazaaleh, Shrouq
    Gonzalez, Adalberto Jose
    Castro, Fernando J.
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) : 477 - 496
  • [10] Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
    Lee, Sejeong
    Bae, Jaehyun
    Jo, Doo Ri
    Lee, Minyoung
    Lee, Yong-ho
    Kang, Eun Seok
    Cha, Bong-Soo
    Lee, Byung-Wan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14